4//SEC Filing
Horne William B. 4
Accession 0001214659-23-003255
CIK 0001677077other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:30 PM ET
Size
10.0 KB
Accession
0001214659-23-003255
Insider Transaction Report
Form 4
Horne William B
Director
Transactions
- Exercise/Conversion
Common Stock
2023-02-24$0.00/sh+500,000$2,000→ 1,000,000 total - Exercise/Conversion
Stock Options (Right to Buy)
2023-02-24−500,000→ 1,500,000 totalExercise: $0.00Exp: 2026-04-29→ Common Stock (500,000 underlying)
Holdings
- 250,000
Stock Options (Right to Buy)
Exercise: $1.50Exp: 2029-11-25→ Common Stock (250,000 underlying) - 250,000
Stock Options (Right to Buy)
Exercise: $1.50Exp: 2029-11-17→ Common Stock (250,000 underlying)
Footnotes (4)
- [F1]This transaction was effected pursuant to Rule 16b-3 with shares of common stock received upon the exercise of stock options.
- [F2]The stock options exercised in this transaction were fully vested and exercisable as of the transaction date.
- [F3]The stock options vest ratably over thirty-six (36) months beginning on the date of grant, and are fully vested.
- [F4]None of these performance-based stock options are vested or exercisable.
Documents
Issuer
Alzamend Neuro, Inc.
CIK 0001677077
Entity typeother
Related Parties
1- filerCIK 0001333268
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:30 PM ET
- Size
- 10.0 KB